ArticleDiscover oncology2026

Baseline vitamin D levels and progression-free survival in patients with HR+/HER2-metastatic breast cancer treated with ribociclib: a retrospective single-center analysis.

Selahattin Çelik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.